North America Legal Cannabis Market to Grow at 25.8% During 2024-2032, Impelled by Favorable Legal Landscape

October 23, 2018 | Healthcare

According to the latest report by IMARC Group, titled "North America Legal Cannabis Market Report by Products Derived (Marijuana, Industrial Hemp, and Others), Distribution Channel (Regulated Dispensary, Recreational Stores, Stand-Alone Retailers, and Others), and Country 2024-2032," the North America legal cannabis market reached a value of US$ 35.6 Billion in 2023. The cannabis plant belongs to the Cannabaceae family and is cultivated in tropical and temperate areas around the world. Cannabis is known to slow down the activity of the central nervous system and produce hallucinogenic effects. It is commonly derived from the dried leaves and flowers of the plant and can be processed using the simple process of drying and curing them. Also known as weed, hash, marijuana, pot and dope, it is widely used for medical and recreational purposes in the North American region since the regulatory landscape is continually being modified to decriminalize its possession and consumption.

North America Legal Cannabis Market Trends:

The market is primarily driven by the increasing utilization of medical cannabis in the healthcare sector. Cannabis is considered to be a relatively safer treatment option with less severe side-effects for treating numerous ailments, including multiple sclerosis, chronic pain, cancer, social anxiety, depression and post-traumatic stress disorder (PTSD). It is consequently used in combination with other therapies to combat the side-effects and increase the effectiveness of the treatment. The rising awareness regarding the benefits of medical cannabis is, therefore, catalyzing the market growth. The market is further driven by the gradual legalization of marijuana across the region. It has been legalized in 30 states of the United States for medicinal use and in 9 states for both therapeutic as well as recreational purposes. Numerous other states of the country are taking initiatives to legalize the same. Additionally, medical and recreational marijuana is already legalized across Canada. The market is further driven by the implementation of stringent regulations in the region due to which the suppliers have to comply with proper safety control measures and provide consumers with high-quality products. Some of the other factors contributing to the market growth include the growing utilization of industrial hemp across multiple sectors and the extensive research and development (R&D) activities conducted to develop safer forms of cannabis. On account of the aforementioned factors, the market is expected to grow at a CAGR of 25.8% during 2024-2032.

Market Summary:

On the basis of the products derived, the market has been bifurcated into marijuana and industrial hemp. At present, marijuana exhibits a clear dominance in the market. The applications of marijuana are further divided on the basis of medical and recreational uses.
Based on the distribution channel, the market has been classified into regulated dispensaries, recreational stores, stand-alone retailers and others. Among these, regulated dispensaries account for the majority of the total market share.
On the geographical front, the United States holds the leading position in the market.
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players. Some of these players include 22nd Century Group, Inc, Medical Marijuana Inc, Hemp, Inc., Axim Biotechnologies, Inc, Arena Pharmaceuticals, Inc., Canopy Growth Corporation, Aphria Inc., Aurora Cannabis Inc., and Abcann Medicinals Inc.

Report Scope:

Report Features	Details
Base Year of the Analysis	2023
Historical Period	2018-2023
Forecast Period	2024-2032
Units	US$ Billion
Segment Coverage	Products Derived, Distribution Channel, Region
Countries Covered	United States, Canada
Companies Covered	22nd Century Group, Inc, Medical Marijuana Inc, Hemp, Inc., Axim Biotechnologies, Inc, Arena Pharmaceuticals, Inc., Canopy Growth Corporation, Aphria Inc., Aurora Cannabis Inc. and Abcann Medicinals Inc.
Customization Scope	10% Free Customization
Report Price and Purchase Option	Single User License: US$ 3699 Five User License: US$ 4699 Corporate License: US$ 5699
Post-Sale Analyst Support	10-12 Weeks
Delivery Format	PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
USA: +1-631-791-1145
Email: sales@imarcgroup.com
Website: https://www.imarcgroup.com
Follow us on twitter: @imarcglobal

Need more help?

Speak to our experienced analysts for insights on the current market scenarios.
Include additional segments and countries to customize the report as per your requirement.
Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
For further assistance, please connect with our analysts.

North America Legal Cannabis Market to Grow at 25.8% During 2024-2032, Impelled by Favorable Legal Landscape

Purchase options

Single User License ~~$3699~~ $2899
Five User License ~~$4699~~ $3899
Corporate User License ~~$5699~~ $4899

Inquire Before Buying

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Speak to an Analyst

Request Brochure

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.